ArticleThoracic cancer2026

Tumor Necrosis on Routine Pretreatment CT as a Potential Prognostic Marker in Advanced NSCLC Treated With Immune Checkpoint Inhibitor Monotherapy: A Two-Center Retrospective Study.

Eiji Takeuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.